Zhou Lin Liu

Title: Innovations by Zhou Lin Liu in Parkinson's Disease Treatment.

Introduction

Zhou Lin Liu is an accomplished inventor based in Guangzhou, China. He has made significant contributions to the field of medical science, particularly in the treatment of neurodegenerative diseases.

Latest Patents

Zhou Lin Liu holds a patent for "Sporoderm-broken germination-activated ganoderma lucidum spores for protection of dopaminergic neurons and treatment of Parkinson's disease." This invention provides a method for treating Parkinson's disease, especially in its early stages. By orally administering sporoderm-broken germination activated spore powders (GASP) to mammals, the invention aims to reduce symptoms of rotatory behavior in Parkinson's disease, slow down neuron apoptosis, and enhance the activity of tyrosine hydroxylase (TH). This process increases the conversion of hydroxydopamine (DOPA) to dopamine in dopaminergic neurons, offering a promising approach to managing this debilitating condition.

Career Highlights

Zhou Lin Liu is associated with Enhan Technology Holdings International Co., Ltd., where he continues to innovate and develop solutions for health-related challenges. His work is characterized by a strong focus on improving the quality of life for individuals suffering from neurological disorders.

Collaborations

Zhou Lin Liu collaborates with Chee-Keung Chung, contributing to advancements in their field through shared expertise and innovative ideas.

Conclusion

Zhou Lin Liu's work exemplifies the intersection of innovation and healthcare, particularly in addressing the challenges posed by Parkinson's disease. His contributions are paving the way for new treatment methodologies that could significantly impact patient care.